CE Mark for Abbott Insertable Heart Monitor

Image credit: Abbott

Abbott’s Assert-IQ insertable cardiac monitor (ICM), which provides diagnostics and long-term monitoring of patients with abnormal heartbeats, has received CE Marking in Europe.

The technology is implanted via a minimally invasive procedure under the skin of a patient’s chest. It then wirelessly sends signals to a transmitter – often the patient’s own smartphone – providing real-time, “clinically actionable” data and enabling remote programming by clinicians.

Assert-IQ is also claimed to offer the world’s longest battery life for a Bluetooth-enabled ICM.

“As the prevalence of abnormal heart rhythms rise, physicians increasingly rely on ICM technology to diagnosis various heart conditions,” said Abbot executive, Dr Leonard Ganz in a statement.

“Introducing Assert-IQ in Europe will expand access to transformative benefits of long-term monitoring and more clinically relevant information, and allow care providers to make clinical decisions faster and with more precision.”

Refer to the full press statement for further details.